A comprehensive multiplex PCR based exome-sequencing assay for rapid bloodspot confirmation of inborn errors of metabolism
Abstract Background Tandem mass spectrometry (MS MS) and simple fluorometric assays are currently used in newborn screening programs to detect inborn errors of metabolism (IEM). The aim of the study was to evaluate the clinical utility of exome sequencing as a second tier screening method to assist...
Saved in:
Main Authors: | Wenjie Wang (Author), Jianping Yang (Author), Jinjie Xue (Author), Wenjuan Mu (Author), Xiaogang Zhang (Author), Wang Wu (Author), Mengnan Xu (Author), Yuyan Gong (Author), Yiqian Liu (Author), Yu Zhang (Author), Xiaobing Xie (Author), Weiyue Gu (Author), Jigeng Bai (Author), David S. Cram (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism
by: Alice Bessey, et al.
Published: (2020) -
Processing Newborn Bloodspot Screening Results for CF
by: Jürg Barben, et al.
Published: (2020) -
Confirming Multiplex RT-qPCR Use in COVID-19 with Next-Generation Sequencing: Strategies for Epidemiological Advantage
by: Rob E. Carpenter, et al.
Published: (2022) -
Expanding Neonatal Bloodspot Screening: A Multi-Stakeholder Perspective
by: Tessa van Dijk, et al.
Published: (2021) -
Counting Conditions on Newborn Bloodspot Screening Panels in Australia and New Zealand
by: Natasha Heather, et al.
Published: (2024)